CLONAZEPAM SUMMARY
Clonazepam Tablets USP C-IV Rx only
Clonazepam, a benzodiazepine, is available as an orally disintegrating tablet containing 0.125 mg, 0.25 mg, 0.5 mg, 1 mg or 2 mg clonazepam.
Seizure Disorders:
Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures. In patients with absence seizures (petit mal) who have failed to respond to succinimides, clonazepam may be useful.
In some studies, up to 30% of patients have shown a loss of anticonvulsant activity, often within 3 months of administration. In some cases, dosage adjustment may reestablish efficacy.
Panic Disorder:
Clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks.
The efficacy of clonazepam was established in two 6- to 9-week trials in panic disorder patients whose diagnoses corresponded to the DSM-IIIR category of panic disorder (see CLINICAL PHARMACOLOGY, Clinical Trials).
Panic disorder (DSM-IV) is characterized by recurrent unexpected panic attacks, i.e., a discrete period of intense fear or discomfort in which four (or more) of the following symptoms develop abruptly and reach a peak within 10 minutes: (1) palpitations, pounding heart or accelerated heart rate; (2) sweating; (3) trembling or shaking; (4) sensations of shortness of breath or smothering; (5) feeling of choking; (6) chest pain or discomfort; (7) nausea or abdominal distress; (8) feeling dizzy, unsteady, lightheaded or faint; (9) derealization (feelings of unreality) or depersonalization (being detached from oneself); (10) fear of losing control; (11) fear of dying; (12) paresthesias (numbness or tingling sensations); (13) chills or hot flushes.
The effectiveness of clonazepam in long-term use, that is, for more than 9 weeks, has not been systematically studied in controlled clinical trials. The physician who elects to use clonazepam for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient (see DOSAGE AND ADMINISTRATION).
|
CLONAZEPAM NEWS HIGHLIGHTS
Published Studies Related to Clonazepam
Clonazepam quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry in a bioequivalence study. [2007.01] A rapid, sensitive and specific method for quantifying clonazepam in human plasma using diazepam as the internal standard (IS) is described. The analyte and the IS were extracted from plasma by liquid-liquid extraction using a hexane/diethylether (20 : 80, v/v) solution... This HPLC/MS/MS procedure was used to assess the bioequivalence of two clonazepam 2 mg tablet formulations (clonazepam test formulation from Ranbaxy Laboratories Ltd and Rivotril from Roche Laboratorios Ltda as standard reference formulation).
Clinical Trials Related to Clonazepam
Bioavailability Study of Clonazepam Tablets Under Fasting Conditions [Completed]
Bioavailability Study of Clonazepam ODT Under Fasting Conditions [Completed]
Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder [Completed]
Post-Traumatic Stress Disorder (PTSD) is an anxiety disorder that follows exposure to an
extremely traumatic stressors. PTSD is associated with serious symptoms. While numerous
approaches have been used to treat PTSD, these treatments have several limiting factors. This
study will evaluate a combination of the drugs clonazepam and paroxetine for the treatment of
PTSD symptoms.
The main goal of treatment in patients with PTSD is to significantly reduce symptom severity
and improve functioning. While numerous approaches have been used to treat PTSD, these
treatments are limited by variable response rates, up to a 6-week lag period before clinical
response, and sub-optimal side effect profile, including possible worsening of anxiety and
insomnia prior to clinical response. The proposed study will examine whether combined
treatment with a benzodiazepine (clonazepam) and a selective serotonin reuptake inhibitor
(paroxetine) in patients with PTSD will accelerate the onset of clinical response. A second
goal is to evaluate whether the rapid and clinically meaningful benefits are sustained until
the end of the study, despite tapering off the benzodiazepine at the midpoint of the study.
The safety and tolerability of a combination of paroxetine and clonazepam will be compared to
paroxetine and placebo (an inactive pill) in the treatment of PTSD.
Participants in this study will be randomly assigned to receive either paroxetine plus
clonazepam or paroxetine plus a placebo for 12 weeks. Participants will have weekly clinic
visits for the first 4 weeks of the study and every other week for the last 8 weeks. Symptoms
of PTSD, anxiety, and depression will be evaluated and drug side effects will be noted during
the follow-up visits.
Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression [Completed]
The purpose of this study is to examine the safety and effectiveness of the drug combination
paroxetine and clonazepam in treating people with panic disorder (PD) and major depression.
The main goal in treating people with PD is to rapidly reduce symptom severity and improve
functioning. While numerous drug therapies have been used to treat PD, these treatments are
limited by variable response rates and suboptimal side effect profiles. Evidence suggests
that clonazepam given with a selective serotonin reuptake inhibitor (SSRI) can facilitate a
rapid reduction in PD symptoms. However, it is unclear whether comorbid depression influences
treatment response to the clonazepam and SSRI regimen. This study will examine whether
combined treatment with clonazepam and the SSRI paroxetine will accelerate clinical response
in participants with PD and comorbid depression. This study will also examine whether the
benefits of treatment will be sustained until the end of the study despite tapering of
clonazepam at the midpoint of the study.
Participants in this study will be screened with medical and psychiatric interviews, a
physical examination, electrocardiogram (ECG), and blood tests. Participants will then be
randomly assigned to receive either paroxetine plus clonazepam or paroxetine plus placebo (an
inactive pill) for 12 weeks. Participants will have weekly clinic visits during which
symptoms and drug side effects will be checked and an interview to evaluate panic disorder
and depression symptoms will be conducted.
Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures [Recruiting]
Evaluate the safety and efficacy of intranasal Clonazepam in subjects with epilepsy.
|
CLONAZEPAM PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 3 ratings/reviews, Clonazepam has an overall score of 5.33. The effectiveness score is 6 and the side effect score is 8.67. The scores are on ten point scale: 10 - best, 1 - worst.
| | Clonazepam review by 43 year old female patient | | | Rating |
| Overall rating: | |           |
| Effectiveness: | | Moderately Effective |
| Side effects: | | No Side Effects | | | Treatment Info |
| Condition / reason: | | insomnia and anxiety |
| Dosage & duration: | | 2 mg per day taken once a day for the period of 1.5 years |
| Other conditions: | | depression, agorophobia and BDD |
| Other drugs taken: | | prozac and seroquel | | | Reported Results |
| Benefits: | | Prozac makes me feel just stabilized not really "Happy",it really just levels me out so i can cope with everyday life and the stresses involved. It was one of the better medications i have tried and have tried several over the past few years that really did nothing. Seroquel was also prescribed for sleeping . I took that in combination with the clonazepam |
| Side effects: | | prozac affects my sex drive mostly and i get headaches, the clonazepam i really don't feel any side effects except it doesn't always work and the seroquel puts on water weight gain makes you ravenous and can leave you feeling disoriented if you do not get enough sleep |
| Comments: | | i am being treated for several disorders and will most likely remain on meds for life as i have recurrent depression and chronic insomnia. The phobia seems to dissapate but it can also return again as i have developed it twice, or i could develop another phobia. In essence i have relapsed seen a psychiatrist, a counsellor, and my doctor along with the medications as part of my treatment program over the last 1.5 years |
|
| | Clonazepam review by 57 year old female patient | | | Rating |
| Overall rating: | |           |
| Effectiveness: | | Marginally Effective |
| Side effects: | | Mild Side Effects | | | Treatment Info |
| Condition / reason: | | Blepharospasm |
| Dosage & duration: | | 1 mg taken 1/day for the period of 3 months - still taking it |
| Other conditions: | | none |
| Other drugs taken: | | none | | | Reported Results |
| Benefits: | | Very slight reduction in muscle spasms around eyes. Ended up also getting light Botox injections in eyelid muscles. This combo therapy has not resulted in a total cessation of eyelid spasms, but has reduced them enough so that I can drive again (the main disability caused by the blepharospasm). Taking the clonazepam at night also helps me get a better night's rest than before I took it. |
| Side effects: | | The first few days I took it I was dizzy and very sleepy. However, those side effects have now subsided. |
| Comments: | | Take 1 MG tab at night before bed. As mentioned above, also got Botox injections to reduce eyelid spasmx. |
|
| | Clonazepam review by 57 year old female patient | | | Rating |
| Overall rating: | |           |
| Effectiveness: | | Marginally Effective |
| Side effects: | | Mild Side Effects | | | Treatment Info |
| Condition / reason: | | Blepharospasm |
| Dosage & duration: | | 1 mg taken 1/day for the period of 3 months - still taking it |
| Other conditions: | | none |
| Other drugs taken: | | none | | | Reported Results |
| Benefits: | | Very slight reduction in muscle spasms around eyes. Ended up also getting light Botox injections in eyelid muscles. This combo therapy has not resulted in a total cessation of eyelid spasms, but has reduced them enough so that I can drive again (the main disability caused by the blepharospasm). Taking the clonazepam at night also helps me get a better night's rest than before I took it. |
| Side effects: | | The first few days I took it I was dizzy and very sleepy. However, those side effects have now subsided. |
| Comments: | | Take 1 MG tab at night before bed. As mentioned above, also got Botox injections to reduce eyelid spasmx. |
|
|
|
Page last updated: 2007-05-03
|